Viemed Healthcare, Inc.

VMD Nasdaq SEC CIK 1729149
Follow Viemed Healthcare Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $80.7M +12.2% vs same quarter last year
Net income $4.6M +32% vs same quarter last year
EPS, diluted $0.11 +22.2% vs same quarter last year
Operating cash flow $11.5M −37.5% vs same quarter last year
Revenue by quarter
$60.7M
$59.1M
$63.1M
$71.9M
$76.2M
$75.4M
$78.1M
$80.7M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income9 fiscal years
  • Revenue
  • Net income
$0$100M$200M$300MFY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$270.3M$15.4M
FY24$224.3M$11.4M
FY23$183M$10.2M
FY22$138.8M$6.2M
FY21$117.1M$9.1M
FY20$131.3M$31.5M
FY19$80.3M$8.5M
FY18$64.5M$9.5M
FY17--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%80%FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2557.5%8.5%5.7%
FY2459.4%8%5.1%
FY2361.6%7.8%5.6%
FY2261%5.9%4.5%
FY2162.7%9.9%7.8%
FY2061%20.4%24%
FY1969.8%11%10.6%
FY1874.1%15.6%14.7%
FY17---
Free cash flowOperating cash flow minus capital expenditure
$0$10M$20M$30MFY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$11.9M
FY24$1.3M
FY23$19.1M
FY22$4.9M
FY21$2.8M
FY20$22.1M
FY19$5.7M
FY18$16.3M
FY17-
Returned to shareholdersDividends paid and shares bought back
$0$5M$10M$15MFY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearBuybacks
FY25$13.2M
FY24$0
FY23$0
FY22$9.6M
FY21$0
FY20$0
FY19$1.5M
FY18$1.6M
FY17-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Viemed Healthcare
  • Healthcare median
−100%−50%0%50%FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearViemed HealthcareHealthcare median
FY255.7%−30.6%
FY245.1%−47%
FY235.6%−58%
FY224.5%−80.4%
FY217.8%−71.9%
FY2024%−62.2%
FY1910.6%−46.3%
FY1814.7%−49.6%
FY17-−45.9%